Picture of CorVel logo

CRVL — CorVel Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual income statement for CorVel, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
2026
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue646719795896959
Cost of Revenue
Gross Profit152158172210233
Selling / General / Administrative Expenses
Total Operating Expenses562634700775815
Operating Profit84.584.695.1121143
Net Income Before Taxes84.584.695.1121143
Provision for Income Taxes
Net Income After Taxes66.466.476.395.2110
Net Income Before Extraordinary Items
Net Income66.466.476.395.2110
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income66.466.476.395.2110
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS1.221.261.471.832.14